|
ERI2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.21950000004012E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.245000E-04 |
| Normal-vs-Stage2 |
9.259500E-02 |
| Normal-vs-Stage3 |
4.05399999999778E-05 |
| Normal-vs-Stage4 |
1.40889999999949E-07 |
| Stage1-vs-Stage2 |
8.264200E-01 |
| Stage1-vs-Stage3 |
9.749600E-02 |
| Stage1-vs-Stage4 |
1.585710E-02 |
| Stage2-vs-Stage3 |
2.115000E-01 |
| Stage2-vs-Stage4 |
1.433550E-01 |
| Stage3-vs-Stage4 |
8.209400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.6748999999725E-06 |
| Normal-vs-AfricanAmerican |
3.576900E-03 |
| Normal-vs-Asian |
2.457400E-01 |
| Caucasian-vs-AfricanAmerican |
9.682600E-01 |
| Caucasian-vs-Asian |
6.993800E-01 |
| AfricanAmerican-vs-Asian |
6.685800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.7427000000927E-07 |
| Normal-vs-Female |
2.019800E-03 |
| Male-vs-Female |
1.318020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.194640E-04 |
| Normal-vs-Age(41-60Yrs) |
8.759300E-04 |
| Normal-vs-Age(61-80Yrs) |
3.9539999999727E-06 |
| Normal-vs-Age(81-100Yrs) |
1.379040E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.320000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.160800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.370000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.534200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.731400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.629800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.076400E-01 |
| Normal-vs-Grade 2 |
1.989740E-02 |
| Normal-vs-Grade 3 |
5.54049999990092E-07 |
| Normal-vs-Grade 4 |
5.04707386994596E-12 |
| Grade 1-vs-Grade 2 |
4.350600E-01 |
| Grade 1-vs-Grade 3 |
7.198000E-02 |
| Grade 1-vs-Grade 4 |
3.640500E-04 |
| Grade 2-vs-Grade 3 |
3.766400E-02 |
| Grade 2-vs-Grade 4 |
2.3170999999822E-06 |
| Grade 3-vs-Grade 4 |
7.437900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.062990E-01 |
| Normal-vs-ccB subtype |
1.31720000018376E-07 |
| ccA subtype-vs-ccB subtype |
1.602760E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.204260E-03 |
| Normal-vs-N1 |
8.24860000000482E-05 |
| N0-vs-N1 |
3.139500E-02 |
|
|
